SEARCH

SEARCH BY CITATION

References

  • Barao, I. & Ascensao, J.L. (1998) Human Natural Killer Cells. Archivum Immunologiae et Therapiae Experimentalis Warszawa., 46, 213229.
  • Cooley, S., Burns, L.J., Repka, T. & Miller, J.S. (1999) Natural killer cell cytotoxicity of breast cancer targets is enhanced by two distinct mechanisms of antibody-dependent cellular cytotoxicity against LFA-3 and HER2/neu. Experimental Hematology., 27, 15331541.
  • Crucian, B.E., Moscinski, L.C., Androlewicz, M., Ballester, O.F., Widen, R.H. & Yu, H. (1997) Assessment of intracellular TAP-1 and TAP-2 in conjunction with surface MHC class I in plasma cells from patients with multiple myeloma. British Journal of Haematology, 98, 426432.
  • Cudkowicz, G. & Bennett, M. (1971) Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistant F 1 hybrid mice. Journal of Experimental Medicine, 134, 15131528.
  • Frohn, C., Schlenke, P. & Kirchner, H. (1997) The repertoire of HLA-Cw-specific NK cell receptors CD158 a/b (EB6 and GL183) in individuals with different HLA phenotypes. Immunology, 92, 567570.
  • Frohn, C., Doehn, C., Durek, C., Böhle, A., Schlenke, P., Jocham, D. & Kirchner, H. (2000) Feasibility of the adoptive transfusion of allogenic HLA-matched NK-cells in patients with renal cell carcinoma. Journal of Immunotherapy, 23, 499504.
  • Garrido, F., Cabrera, T., Concha, A., Glew, S., Ruiz Cabello, F. & Stern, P.L. (1993) Natural history of HLA expression during tumour development. Immunology Today, 14, 491499.
  • Gazdar, A.F., Oie, H.K., Kirsch, I.R. & Hollis, G.F. (1986) Establishment and characterization of a human plasma cell myeloma culture having a rearranged cellular myc proto-oncogene. Blood, 67, 15421549.
  • Gottlieb, D.J., Prentice, H.G., Mehta, A.B., Galazka, A.R., Heslop, H.E., Hoffbrand, A.V. & Brenner, M.K. (1990) Malignant plasma cells are sensitive to LAK cell lysis: pre-clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma. British Journal of Haematology, 75, 499505.
  • Gumperz, J.E. & Parham, P. (1995) The enigma of the natural killer cell. Nature, 378, 245248.
  • Höppner, M., Luhm, J., Schlenke, P., Koritke, P. & Frohn, C. (2002) A flow-cytometry based cytotoxicity assay using stained effector cells in combination with native target cells. Journal of Immunological Methods, 267, 157163.
  • Kolb, H.J., Schattenberg, A., Goldman, J.M., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., Niederwieser, D., Vanrhee, F., Mittermueller, J., DeWitte, T., Holler, E. & Ansari, H. (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood, 86, 20412050.
  • Long, E., Colonna, M. & Lanier, L.L. (1996) Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature. Immunology Today, 17, 100 .
  • Lotzova, E., Savary, C.A. & Herberman, R.B. (1987a) Inhibition of clonogenic growth of fresh leukemia cells by unstimulated and IL-2 stimulated NK cells of normal donors. Leukaemia Research, 11, 10591066.
  • Lotzova, E., Savary, C.A. & Herberman, R.B. (1987b) Induction of NK cell activity against fresh human leukemia in culture with interleukin 2. Journal of Immunology, 138, 27182727.
  • Matsuoka, Y., Moore, G.E., Yagi, Y. & Pressman, D. (1967) Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proceedings of the Society for Experimental and Biological Medicine, 125, 12461250.
  • Miller, J.S., Verfaillie, C. & McGlave, P. (1991) Adherent lymphokine-activated killer cells suppress autologous human normal bone marrow progenitors. Blood, 77, 23892395.
  • Multhoff, G., Botzler, C., Jennen, L., Schmidt, J., Ellwart, J. & Issels, R. (1997) Heat shock protein 72 on tumor cells: a recognition structure for natural killer cells. Journal of Immunology, 158, 43414350.
  • Nilsson, K. (1971) Synthesis and secretion of IgE by an established human myeloma cell line. Clinical Experimental Immunology, 9, 785793.
  • Sentman, C.L., Olsson, M.Y., Salcedo, M., Höglund, P., Lendahl, U. & Kärre, K. (1994) H-2 allele-specific protection from NK cell lysis in vitro for lymphoblasts but not tumor targets. Protection mediated by alpha 1/alpha 2 domains. Journal of Immunology, 153, 54825490.
  • Shimazaki, C., Atzpodien, J., Wisniewski, D., Gulati, S.C., Kolitz, J.E., Fried, J. & Clarkson, B.D. (1988) Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cells. Acta Haematologica, 80, 203209.
  • Slezak, S.E. & Horan, P.K. (1989) Cell-mediated cytotoxicity. A highly sensitive and informative flow cytometric assay. Journal of Immunological Methods, 117, 205214.
  • Titzer, S., Christensen, O., Manzke, O., Tesch, H., Wolf, J., Emmerich, B., Carsten, C., Diehl, V. & Bohlen, H. (2000) Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects. British Journal of Haematology, 108, 805816.
  • Torelli, G.F., Guarini, A., Palmieri, G., Breccia, M., Vitale, A., Santoni, A. & Foa, R. (2002) Expansion of cytotoxic effectors with lytic activity against autologous blasts from acute myeloid leukaemia patients in complete haematological remission. British Journal of Haematology, 116, 299307.
  • Tricot, G., Vesole, D.H., Jagannath, S., Hilton, J., Munshi, N. & Barlogie, B. (1996) Graft-versus-myeloma effect: proof of principle. Blood, 87, 11961198.
  • Trinchieri, G. (1989) Biology of natural killer cells. Advances in Immunology, 47, 187376 .
  • Uharek, L., Zeis, M., Glass, B., Steinmann, J., Dreger, P., Gassmann, W., Schmitz, N. & Muller, R.W. (1996) High lytic activity against human leukemia cells after activation of allogeneic NK cells by IL-12 and IL-2. Leukemia, 10, 17581764.
  • Verdonck, L.F., Lokhorst, H.M., Dekker, A.W., Nieuwenhuis, H.K. & Petersen, E.J. (1996) Graft-versus-myeloma effect in two cases. Lancet, 347, 800801.
  • Young, N.T., Rust, N.A., Dallman, M.J., Cerundolo, V., Morris, P.J. & Welsh, K.I. (1998) Independent contributions of HLA epitopes and killer inhibitory receptor expression to the functional alloreactive specificity of natural killer cells. Human Immunology, 59, 700712.
  • Zeis, M., Uharek, L., Glass, B., Gaska, T., Steinmann, J., Gassmann, W., Loffler, H. & Muller Ruchholtz, W. (1995) Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice. Transplantation, 59, 17341736.